ETFChannel.com
ETF Introduction: IBB — iShares Nasdaq Biotechnology ETF
Market News Video - Monday, April 6, 5:28 PM

Description to the Nasdaq Biotechnology Index Fund, traded under ticker symbol IBB: This ETF is a fund, created in February 2001, that corresponds to the price and yield performance, before fees and expenses, of companies primarily in the biotech sector, as represented by the NASDAQ Biotechnology Index. The underlying index includes securities of Nasdaq listed companies classified according to the Industry Classification Benchmark as either Biotech or Pharma which also meet other eligibility criteria.

Fund Name:
iShares Nasdaq Biotechnology ETF
Issuer:
iShares
Total Net Assets:
$8,612,716,631
Inception:
02/05/2001
Related Index:
NASDAQ Biotechnology Index (NBI)
ETF Category: 
Health
Expense Ratio: 
0.47% 
Net Asset Value: 
$132.00  
Recent NAV Premium: 
0.00% 
NAV Symbol: 
IBB.NV  
Number of Holdings: 
210  
Annualized Yield: 
0.21%  
Annualized Distribution: 
0.275  
IBB Dividend History » 
Stock Weight Amount
Vertex Pharmaceuticals 7.74% $666,582,158
Amgen 7.59% $653,314,485
Gilead Sciences 7.37% $634,761,478
Regeneron Pharmaceuticals 6.47% $557,292,810
Biogen 5.61% $482,938,508
List of all 215 stocks held by IBB »
Quotes delayed 20 minutes

Buy (3.22 out of 4)
65th percentile
(ranked higher than approx. 65% of all etfs covered)
Based on data provided by Zacks Investment Research via Quandl.com
ETF Assets
IVV   $189,020,717,050
AGG   $71,871,401,847
IEFA   $63,696,176,827
IWF   $52,184,216,804
LQD   $48,480,780,228
List of all 347 others »
Shares Short 13,210,000
Chg. from Last Month +1,160,000
Shares Outstanding 65,250,000
% of Shares Short 20.25%
Days to Cover 3.9
Based on third party short interest data.

IBB | iShares Nasdaq Biotechnology ETF | ETF Channel | www.ETFChannel.com

Copyright © 2010 - 2020, All Rights Reserved Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.